Global Medication Therapy Management Market By Type (Software, Services (Medication Therapy Reviews, Pharmacotherapy Consults, Disease Management Support, Pharmacogenomics Applications, Anticoagulation Management, Medication Safety Surveillance, Other Clinical Services)); By End User (Pharmacies, Healthcare Payers); By Region (U.S., Canada, Mexico, Rest of North America, The UK, France, Germany, Italy, Spain, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, the Netherlands, Luxembourg), Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 - 2027
Industry Trends
The healthcare givers and pharmacist are striving to achieve better engagement with patients by providing accurate and complete medication. World Health Organization (WHO) reported in 2017 that 1.3 million U.S citizens die annually due to error in medication. The cost associated with medication error was US$ 42 billion across the globe in the same year. These figures depict the need for counter-measures to arrest medication errors and loss of life and wealth due to these errors. Automated medication management offerings are driving the change in role of pharmacies and other healthcare players in patient assistance. Medication therapy management is a rapidly emerging term in healthcare industry which help patients get the most benefit from their medications. It encompasses a broad range of health care services provided by pharmacists and the medication experts to improve medication use, reduce the risk of adverse events, and improve medication adherence. These services are independent of the medication product, and can also be provided in conjunction. Medication therapy management is a patient-centric and comprehensive approach which improves the quality of care pharmacists offer to patients along with increasing their overall revenue generation and return on investment (ROI). The medication therapy management offerings of medication experts benefits patients with overview of all prescribed medications, medication-related education and consultation through collaboration among patient, physician and other healthcare experts. There are five core elements of a medication therapy management service model including medication therapy review (MTR), personal medication record (PMR), medication-related action plan (MAP), intervention and/or referral, documentation and follow-up. The delivery of these core elements can be customized based on patient’s requirements. Thus, the advantage of medication therapy management, to effectively curb the medication errors causing loss of life and wealth, is fueling the growth of medication therapy management market across the globe.
The ongoing advancements in technology have created a fertile growth environment for IT solution in healthcare industry. The rise in maturity of electronic health records of patients have enabled better patient understanding, medication reconciliation, medication adherence and disease control. Patients with severe illnesses use complex regimes and consult multiple prescribers. The medication therapy management uses a collaborative approach with integration of computerized electronic health records to address the challenges in each phase of the medication cycle by availing real-time patient information to medication experts. For instance, Cerner Corporation’s pharmacy solutions provides in-patient and out-patient drug data through electronic health records to assist with monitoring and assessing patients.
Virtual technologies poses lucrative growth opportunities in medication therapy management. It utilizes video-conferencing technology to connect pharmacist and patients where the pharmacists reviews medical records of patients and provides comprehensive medication therapy management regimen with comparatively lower costs. For instance, Telepharmacy of One Touch Video Chat provides video chat services for counseling, training, or management of patient communications to large as well as small independent pharmacies or consulting pharmacists. The recent outbreak of COVID-19 pandemic has mandated people to practice social distancing for avoiding the spread of this infectious disease. As the patients around the globe are carefully ascertaining their physical visits to doctors and healthcare facilities, the virtual technologies in medication therapy management market are anticipated to witness upsurge in demand. Thus, technological advancements in healthcare sector coupled with the current coronavirus crisis demanding remote services, are poised to boost the growth of global medication therapy management market over forecast years.
As technological advancements in healthcare sector are growing, medication therapy management market players are strategizing on innovation and development of new offerings. The rise in number of patients and their documentation has created complexity in handling and processing these huge datasets, thus posing a challenge for pharmacists and medication experts to deliver efficient medication management services. Cloud based medication therapy management programs are viable solutions for this ever-increasing patient data. For instance, Practice tools offered by Emgenex LLC, is a suite of cloud based software programs, which automates various essential tasks including medication therapy review, drafting medication-related action plan and other functions to provide seamless care. Moreover, industry players in medication therapy management market are innovating products for patients along with medication experts, which is anticipated to expand the range of target customer base . For instance, IQware Personal Medication Therapy Management of IQware Solutions is an offering developed for patients to access medication therapy management from home. Through this solution, patients can record and analyze medications, view drug interactions based on current medications, maintain personal medical record, communicate with health care providers and perform other related activities. Thus, the upcoming innovative offerings are anticipated to propel the growth of global medication therapy management market over the forecast period.
Type Outlook:
Based on type, solutions held significant share in the global medication therapy management market in 2018 owing to high adoption by number of pharmacists and medication experts to resolve medication related problems. Medication therapy management services are becoming highly popular due to rising healthcare awareness among patients. Different services based on the type of patient requirements are delivered. These services include medication therapy reviews, pharmacotherapy consults, disease management support, pharmacogenomics applications, anticoagulation management, medication safety surveillance and others. Pharmacogenomics is a recently emerging service which includes analysis of genetic information of patients which is important for estimating drug response. US Food and Drug Administration agency recognizes pharmacogenomics in drug labelling which can assist medication experts to identify responders and non-responders to medications. A substantial variation in the scope of these services based on the changing medication requirement are being observed globally, which is anticipated to show notable growth in global medication therapy management market over the next eight years.
End User Outlook:
Based on the end users, pharmacies dominated the global medication therapy management market in 2018. Healthcare players are anticipated to show remarkable growth over forecast years owing to new affordable solutions being introduced by industry players in medication therapy management market. For instance the Clinical Care Group, LLC launched a new business platform in November 2017 for independent consultant pharmacists and licensed health care providers which compiles cloud based capabilities for providing medication therapy management services. Thus, the upcoming solutions for newer players in medication field are anticipated boost the growth of healthcare payers in global medication therapy management market over forecast years.
Regional Outlook:
North America region registered the highest share in global medication therapy management market in 2018 owing to government initiative to boost the adoption of medication management services. However, the on-going development in healthcare infrastructure of Asia Pacific region has attracted newer layers to launch their products in this region. For instance, in May 2020, Relex Healthcare announced launch of their medication therapy management program in India. This program enhances medication adherence through a unique home-service model. Hence, the established players are viewing Asia Pacific as a lucrative growth opportunity, and thus investing strategically, thereby contributing towards the region’s growth in global medication therapy management market.
In terms of revenue, global medication therapy management market was valued at US$ 393.19 Mn in 2018 and is anticipated to grow at a CAGR of 8.83% over the forecast period and reach US$ 838.70 Mn by 2027. The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Medication Therapy Management Market Revenue & Forecast, (US$ Million), 2015 – 2027
Competitive Landscape
The report provides both, qualitative and quantitative research of medication therapy management market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the medication therapy management market are AdhereHealth, LLC, Agadia Systems, Inc., Aprexis HS LLC, AssureCare, LLC, Cardinal Health, Cerner Corporation, CSS Health, First Databank, Inc., GemCare Wellness, General Electric Company, Healthcare Fiscal Management, Inc., IQware Solutions, Magellan Health, Inc., McKesson Corporation, Omnicell, Inc., Tabula Rasa HealthCare (Sinfonia Rx) and Centene Corporation (WellCare) amongst others.
Global Medication Therapy Management Market:
- By Type
- Software
- Services
- Medication Therapy Reviews
- Pharmacotherapy Consults
- Disease Management Support
- Pharmacogenomics Applications
- Anticoagulation Management
- Medication Safety Surveillance
- Other Clinical Services
- By End User
- Pharmacies
- Healthcare Payers
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1.
Market
Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2013 - 2017
1.2.2. Base Year: 2018
1.2.3. Forecast Years: 2019 – 2027
2.
Key
Target Audiences
3.
Research
Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders
(KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5.
Holistic
Overview of Medication Therapy Management Market
6.
Market
Synopsis: Medication Therapy Management
Market
7.
Medication
Therapy Management Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in Medication Therapy Management
Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators:
Medication Therapy Management Market
7.6. Porter’s Five Force Analysis
7.7. Analysis on Impact of Covid-19 on Global
Medication Therapy Management Market
8.
Global
Medication Therapy Management Market Analysis and Forecasts, 2019 – 2027
8.1. Overview
8.1.1. Global Medication Therapy Management Market
Revenue (US$ Mn)
8.2. Global Medication Therapy Management Market
Revenue (US$ Mn) and Forecasts, By Type
8.2.1. Software
8.2.1.1.
Definition
8.2.1.2.
Market
Estimation and Penetration, 2013 – 2018
8.2.1.3.
Market
Forecast, 2019 – 2027
8.2.1.4.
Compound
Annual Growth Rate (CAGR)
8.2.1.5.
Regional
Bifurcation
8.2.1.5.1.
North
America
8.2.1.5.1.1. Market Estimation, 2013 – 2018
8.2.1.5.1.2. Market Forecast, 2019 – 2027
8.2.1.5.2.
Europe
8.2.1.5.2.1. Market Estimation, 2013 – 2018
8.2.1.5.2.2. Market Forecast, 2019 – 2027
8.2.1.5.3.
Asia
Pacific
8.2.1.5.3.1. Market Estimation, 2013 – 2018
8.2.1.5.3.2. Market Forecast, 2019 – 2027
8.2.1.5.4.
Middle
East and Africa
8.2.1.5.4.1. Market Estimation, 2013 – 2018
8.2.1.5.4.2. Market Forecast, 2019 – 2027
8.2.1.5.5.
Latin
America
8.2.1.5.5.1. Market Estimation, 2013 – 2018
8.2.1.5.5.2. Market Forecast, 2019 – 2027
8.2.2. Services (Definition, Market Estimation and
Penetration, 2013 – 2018, Market Estimation (2013 – 2018), Market Forecast
(2019 – 2027), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Medication Therapy Reviews, Pharmacotherapy Consults, Disease
Management Support, Pharmacogenomics Applications, Anticoagulation Management,
Medication Safety Surveillance, Other Clinical Services)
8.2.2.1.
Medication
Therapy Reviews
8.2.2.2.
Pharmacotherapy
Consults
8.2.2.3.
Disease
Management Support
8.2.2.4.
Pharmacogenomics
Applications
8.2.2.5.
Anticoagulation
Management
8.2.2.6.
Medication
Safety Surveillance
8.2.2.7.
Other
Clinical Services
8.3. Key Segment for Channeling Investments
8.3.1. By Type
9.
Global
Medication Therapy Management Market Analysis and Forecasts, 2019 – 2027
9.1. Overview
9.2. Global Medication Therapy Management Market
Revenue (US$ Mn) and Forecasts, By End User
9.2.1. Pharmacies
9.2.1.1.
Definition
9.2.1.2.
Market
Estimation and Penetration, 2013 – 2018
9.2.1.3.
Market
Forecast, 2019 – 2027
9.2.1.4.
Compound
Annual Growth Rate (CAGR)
9.2.1.5.
Regional
Bifurcation
9.2.1.5.1.
North
America
9.2.1.5.1.1. Market Estimation, 2013 – 2018
9.2.1.5.1.2. Market Forecast, 2019 – 2027
9.2.1.5.2.
Europe
9.2.1.5.2.1. Market Estimation, 2013 – 2018
9.2.1.5.2.2. Market Forecast, 2019 – 2027
9.2.1.5.3.
Asia
Pacific
9.2.1.5.3.1. Market Estimation, 2013 – 2018
9.2.1.5.3.2. Market Forecast, 2019 – 2027
9.2.1.5.4.
Middle
East and Africa
9.2.1.5.4.1. Market Estimation, 2013 – 2018
9.2.1.5.4.2. Market Forecast, 2019 – 2027
9.2.1.5.5.
Latin
America
9.2.1.5.5.1. Market Estimation, 2013 – 2018
9.2.1.5.5.2. Market Forecast, 2019 – 2027
9.2.2. Healthcare Payers
9.2.2.1.
Definition
9.2.2.2.
Market
Estimation and Penetration, 2013 – 2018
9.2.2.3.
Market
Forecast, 2019 – 2027
9.2.2.4.
Compound
Annual Growth Rate (CAGR)
9.2.2.5.
Regional
Bifurcation
9.2.2.5.1.
North
America
9.2.2.5.1.1. Market Estimation, 2013 – 2018
9.2.2.5.1.2. Market Forecast, 2019 – 2027
9.2.2.5.2.
Europe
9.2.2.5.2.1. Market Estimation, 2013 – 2018
9.2.2.5.2.2. Market Forecast, 2019 – 2027
9.2.2.5.3.
Asia
Pacific
9.2.2.5.3.1. Market Estimation, 2013 – 2018
9.2.2.5.3.2. Market Forecast, 2019 – 2027
9.2.2.5.4.
Middle
East and Africa
9.2.2.5.4.1. Market Estimation, 2013 – 2018
9.2.2.5.4.2. Market Forecast, 2019 – 2027
9.2.2.5.5.
Latin
America
9.2.2.5.5.1. Market Estimation, 2013 – 2018
9.2.2.5.5.2. Market Forecast, 2019 – 2027
9.3. Key Segment for Channeling Investments
9.3.1. By End User
10. North America Medication Therapy Management
Market Analysis and Forecasts, 2019 - 2027
10.1. Overview
10.1.1. North America Medication Therapy Management
Market Revenue (US$ Mn)
10.2. North America Medication Therapy Management
Market Revenue (US$ Mn) and Forecasts, By Type
10.2.1. Software
10.2.2. Services
10.2.2.1.
Medication
Therapy Reviews
10.2.2.2.
Pharmacotherapy
Consults
10.2.2.3.
Disease
Management Support
10.2.2.4.
Pharmacogenomics
Applications
10.2.2.5.
Anticoagulation
Management
10.2.2.6.
Medication
Safety Surveillance
10.2.2.7.
Other
Clinical Services
10.3. North America Medication Therapy Management
Market Revenue (US$ Mn) and Forecasts, By End User
10.3.1. Pharmacies
10.3.2. Healthcare Payers
10.4. North America Medication Therapy Management
Market Revenue (US$ Mn) and Forecasts, By Country
10.4.1. U.S
10.4.1.1.
U.S
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By Type
10.4.1.1.1.
Software
10.4.1.1.2.
Services
10.4.1.1.2.1. Medication Therapy Reviews
10.4.1.1.2.2. Pharmacotherapy Consults
10.4.1.1.2.3. Disease Management Support
10.4.1.1.2.4. Pharmacogenomics Applications
10.4.1.1.2.5. Anticoagulation Management
10.4.1.1.2.6. Medication Safety Surveillance
10.4.1.1.2.7. Other Clinical Services
10.4.1.2.
U.S
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By End
User
10.4.1.2.1.
Pharmacies
10.4.1.2.2.
Healthcare
Payers
10.4.2. Canada
10.4.2.1.
Canada
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By Type
10.4.2.1.1.
Software
10.4.2.1.2.
Services
10.4.2.1.2.1. Medication Therapy Reviews
10.4.2.1.2.2. Pharmacotherapy Consults
10.4.2.1.2.3. Disease Management Support
10.4.2.1.2.4. Pharmacogenomics Applications
10.4.2.1.2.5. Anticoagulation Management
10.4.2.1.2.6. Medication Safety Surveillance
10.4.2.1.2.7. Other Clinical Services
10.4.2.2.
Canada
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By End
User
10.4.2.2.1.
Pharmacies
10.4.2.2.2.
Healthcare
Payers
10.4.3. Mexico
10.4.3.1.
Mexico
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By Type
10.4.3.1.1.
Software
10.4.3.1.2.
Services
10.4.3.1.2.1. Medication Therapy Reviews
10.4.3.1.2.2. Pharmacotherapy Consults
10.4.3.1.2.3. Disease Management Support
10.4.3.1.2.4. Pharmacogenomics Applications
10.4.3.1.2.5. Anticoagulation Management
10.4.3.1.2.6. Medication Safety Surveillance
10.4.3.1.2.7. Other Clinical Services
10.4.3.2.
Mexico
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By End
User
10.4.3.2.1.
Pharmacies
10.4.3.2.2.
Healthcare
Payers
10.4.4. Rest of North America
10.4.4.1.
Rest of
North America Medication Therapy Management Market Revenue (US$ Mn) and
Forecasts, By Type
10.4.4.1.1.
Software
10.4.4.1.2.
Services
10.4.4.1.2.1. Medication Therapy Reviews
10.4.4.1.2.2. Pharmacotherapy Consults
10.4.4.1.2.3. Disease Management Support
10.4.4.1.2.4. Pharmacogenomics Applications
10.4.4.1.2.5. Anticoagulation Management
10.4.4.1.2.6. Medication Safety Surveillance
10.4.4.1.2.7. Other Clinical Services
10.4.4.2.
Rest of
North America Medication Therapy Management Market Revenue (US$ Mn) and
Forecasts, By End User
10.4.4.2.1.
Pharmacies
10.4.4.2.2.
Healthcare
Payers
10.5. Key Segment for Channeling Investments
10.5.1. By Country
10.5.2. By Type
10.5.3. By End User
11. Europe Medication Therapy Management Market
Analysis and Forecasts, 2019 - 2027
11.1. Overview
11.1.1. Europe Medication Therapy Management Market
Revenue (US$ Mn)
11.2. Europe Medication Therapy Management Market
Revenue (US$ Mn) and Forecasts, By Type
11.2.1. Software
11.2.2. Services
11.2.2.1.
Medication
Therapy Reviews
11.2.2.2.
Pharmacotherapy
Consults
11.2.2.3.
Disease
Management Support
11.2.2.4.
Pharmacogenomics
Applications
11.2.2.5.
Anticoagulation
Management
11.2.2.6.
Medication
Safety Surveillance
11.2.2.7.
Other
Clinical Services
11.3. Europe Medication Therapy Management Market
Revenue (US$ Mn) and Forecasts, By End User
11.3.1. Pharmacies
11.3.2. Healthcare Payers
11.4. Europe Medication Therapy Management Market
Revenue (US$ Mn) and Forecasts, By Country
11.4.1. France
11.4.1.1.
France Medication
Therapy Management Market Revenue (US$ Mn) and Forecasts, By Type
11.4.1.1.1.
Software
11.4.1.1.2.
Services
11.4.1.1.2.1. Medication Therapy Reviews
11.4.1.1.2.2. Pharmacotherapy Consults
11.4.1.1.2.3. Disease Management Support
11.4.1.1.2.4. Pharmacogenomics Applications
11.4.1.1.2.5. Anticoagulation Management
11.4.1.1.2.6. Medication Safety Surveillance
11.4.1.1.2.7. Other Clinical Services
11.4.1.2.
France
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By End
User
11.4.1.2.1.
Pharmacies
11.4.1.2.2.
Healthcare
Payers
11.4.2. The UK
11.4.2.1.
The UK
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By Type
11.4.2.1.1.
Software
11.4.2.1.2.
Services
11.4.2.1.2.1. Medication Therapy Reviews
11.4.2.1.2.2. Pharmacotherapy Consults
11.4.2.1.2.3. Disease Management Support
11.4.2.1.2.4. Pharmacogenomics Applications
11.4.2.1.2.5. Anticoagulation Management
11.4.2.1.2.6. Medication Safety Surveillance
11.4.2.1.2.7. Other Clinical Services
11.4.2.2.
The UK
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By End
User
11.4.2.2.1.
Pharmacies
11.4.2.2.2.
Healthcare
Payers
11.4.3. Spain
11.4.3.1.
Spain
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By Type
11.4.3.1.1.
Software
11.4.3.1.2.
Services
11.4.3.1.2.1. Medication Therapy Reviews
11.4.3.1.2.2. Pharmacotherapy Consults
11.4.3.1.2.3. Disease Management Support
11.4.3.1.2.4. Pharmacogenomics Applications
11.4.3.1.2.5. Anticoagulation Management
11.4.3.1.2.6. Medication Safety Surveillance
11.4.3.1.2.7. Other Clinical Services
11.4.3.2.
Spain
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By End
User
11.4.3.2.1.
Pharmacies
11.4.3.2.2.
Healthcare
Payers
11.4.4. Germany
11.4.4.1.
Germany
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By Type
11.4.4.1.1.
Software
11.4.4.1.2.
Services
11.4.4.1.2.1. Medication Therapy Reviews
11.4.4.1.2.2. Pharmacotherapy Consults
11.4.4.1.2.3. Disease Management Support
11.4.4.1.2.4. Pharmacogenomics Applications
11.4.4.1.2.5. Anticoagulation Management
11.4.4.1.2.6. Medication Safety Surveillance
11.4.4.1.2.7. Other Clinical Services
11.4.4.2.
Germany
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By End
User
11.4.4.2.1.
Pharmacies
11.4.4.2.2.
Healthcare
Payers
11.4.5. Italy
11.4.5.1.
Italy
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By Type
11.4.5.1.1.
Software
11.4.5.1.2.
Services
11.4.5.1.2.1. Medication Therapy Reviews
11.4.5.1.2.2. Pharmacotherapy Consults
11.4.5.1.2.3. Disease Management Support
11.4.5.1.2.4. Pharmacogenomics Applications
11.4.5.1.2.5. Anticoagulation Management
11.4.5.1.2.6. Medication Safety Surveillance
11.4.5.1.2.7. Other Clinical Services
11.4.5.2.
Italy
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By End
User
11.4.5.2.1.
Pharmacies
11.4.5.2.2.
Healthcare
Payers
11.4.6. Nordic Countries
11.4.6.1.
Nordic
Countries Medication Therapy Management Market Revenue (US$ Mn) and Forecasts,
By Type
11.4.6.1.1.
Software
11.4.6.1.2.
Services
11.4.6.1.2.1. Medication Therapy Reviews
11.4.6.1.2.2. Pharmacotherapy Consults
11.4.6.1.2.3. Disease Management Support
11.4.6.1.2.4. Pharmacogenomics Applications
11.4.6.1.2.5. Anticoagulation Management
11.4.6.1.2.6. Medication Safety Surveillance
11.4.6.1.2.7. Other Clinical Services
11.4.6.2.
Nordic
Countries Medication Therapy Management Market Revenue (US$ Mn) and Forecasts,
By End User
11.4.6.2.1.
Pharmacies
11.4.6.2.2.
Healthcare
Payers
11.4.6.3.
Nordic
Countries Medication Therapy Management Market Revenue (US$ Mn) and Forecasts,
By Country
11.4.6.3.1.
Denmark
11.4.6.3.2.
Finland
11.4.6.3.3.
Iceland
11.4.6.3.4.
Sweden
11.4.6.3.5.
Norway
11.4.7. Benelux Union
11.4.7.1.
Benelux
Union Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By
Type
11.4.7.1.1.
Software
11.4.7.1.2.
Services
11.4.7.1.2.1. Medication Therapy Reviews
11.4.7.1.2.2. Pharmacotherapy Consults
11.4.7.1.2.3. Disease Management Support
11.4.7.1.2.4. Pharmacogenomics Applications
11.4.7.1.2.5. Anticoagulation Management
11.4.7.1.2.6. Medication Safety Surveillance
11.4.7.1.2.7. Other Clinical Services
11.4.7.2.
Benelux
Union Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By
End User
11.4.7.2.1.
Pharmacies
11.4.7.2.2.
Healthcare
Payers
11.4.7.3.
Benelux
Union Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By
Country
11.4.7.3.1.
Belgium
11.4.7.3.2.
The
Netherlands
11.4.7.3.3.
Luxembourg
11.4.8. Rest of Europe
11.4.8.1.
Rest of
Europe Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By
Type
11.4.8.1.1.
Software
11.4.8.1.2.
Services
11.4.8.1.2.1. Medication Therapy Reviews
11.4.8.1.2.2. Pharmacotherapy Consults
11.4.8.1.2.3. Disease Management Support
11.4.8.1.2.4. Pharmacogenomics Applications
11.4.8.1.2.5. Anticoagulation Management
11.4.8.1.2.6. Medication Safety Surveillance
11.4.8.1.2.7. Other Clinical Services
11.4.8.2.
Rest of
Europe Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By
End User
11.4.8.2.1.
Pharmacies
11.4.8.2.2.
Healthcare
Payers
11.5. Key Segment for Channeling Investments
11.5.1. By Country
11.5.2. By Type
11.5.3. By End User
12. Asia Pacific Medication Therapy Management
Market Analysis and Forecasts, 2019 - 2027
12.1. Overview
12.1.1. Asia Pacific Medication Therapy Management
Market Revenue (US$ Mn)
12.2. Asia Pacific Medication Therapy Management
Market Revenue (US$ Mn) and Forecasts, By Type
12.2.1. Software
12.2.2. Services
12.2.2.1.
Medication
Therapy Reviews
12.2.2.2.
Pharmacotherapy
Consults
12.2.2.3.
Disease
Management Support
12.2.2.4.
Pharmacogenomics
Applications
12.2.2.5.
Anticoagulation
Management
12.2.2.6.
Medication
Safety Surveillance
12.2.2.7.
Other
Clinical Services
12.3. Asia Pacific Medication Therapy Management
Market Revenue (US$ Mn) and Forecasts, By End User
12.3.1. Pharmacies
12.3.2. Healthcare Payers
12.4. Asia Pacific Medication Therapy Management
Market Revenue (US$ Mn) and Forecasts, By Country
12.4.1. China
12.4.1.1.
China
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By Type
12.4.1.1.1.
Software
12.4.1.1.2.
Services
12.4.1.1.2.1. Medication Therapy Reviews
12.4.1.1.2.2. Pharmacotherapy Consults
12.4.1.1.2.3. Disease Management Support
12.4.1.1.2.4. Pharmacogenomics Applications
12.4.1.1.2.5. Anticoagulation Management
12.4.1.1.2.6. Medication Safety Surveillance
12.4.1.1.2.7. Other Clinical Services
12.4.1.2.
China
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By End
User
12.4.1.2.1.
Pharmacies
12.4.1.2.2.
Healthcare
Payers
12.4.2. Japan
12.4.2.1.
Japan
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By Type
12.4.2.1.1.
Software
12.4.2.1.2.
Services
12.4.2.1.2.1. Medication Therapy Reviews
12.4.2.1.2.2. Pharmacotherapy Consults
12.4.2.1.2.3. Disease Management Support
12.4.2.1.2.4. Pharmacogenomics Applications
12.4.2.1.2.5. Anticoagulation Management
12.4.2.1.2.6. Medication Safety Surveillance
12.4.2.1.2.7. Other Clinical Services
12.4.2.2.
Japan
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By End
User
12.4.2.2.1.
Pharmacies
12.4.2.2.2.
Healthcare
Payers
12.4.3. India
12.4.3.1.
India
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By Type
12.4.3.1.1.
Software
12.4.3.1.2.
Services
12.4.3.1.2.1. Medication Therapy Reviews
12.4.3.1.2.2. Pharmacotherapy Consults
12.4.3.1.2.3. Disease Management Support
12.4.3.1.2.4. Pharmacogenomics Applications
12.4.3.1.2.5. Anticoagulation Management
12.4.3.1.2.6. Medication Safety Surveillance
12.4.3.1.2.7. Other Clinical Services
12.4.3.2.
India
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By End
User
12.4.3.2.1.
Pharmacies
12.4.3.2.2.
Healthcare
Payers
12.4.4. New Zealand
12.4.4.1.
New
Zealand Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By
Type
12.4.4.1.1.
Software
12.4.4.1.2.
Services
12.4.4.1.2.1. Medication Therapy Reviews
12.4.4.1.2.2. Pharmacotherapy Consults
12.4.4.1.2.3. Disease Management Support
12.4.4.1.2.4. Pharmacogenomics Applications
12.4.4.1.2.5. Anticoagulation Management
12.4.4.1.2.6. Medication Safety Surveillance
12.4.4.1.2.7. Other Clinical Services
12.4.4.2.
New
Zealand Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By
End User
12.4.4.2.1.
Pharmacies
12.4.4.2.2.
Healthcare
Payers
12.4.5. Australia
12.4.5.1.
Australia
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By Type
12.4.5.1.1.
Software
12.4.5.1.2.
Services
12.4.5.1.2.1. Medication Therapy Reviews
12.4.5.1.2.2. Pharmacotherapy Consults
12.4.5.1.2.3. Disease Management Support
12.4.5.1.2.4. Pharmacogenomics Applications
12.4.5.1.2.5. Anticoagulation Management
12.4.5.1.2.6. Medication Safety Surveillance
12.4.5.1.2.7. Other Clinical Services
12.4.5.2.
Australia
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By End
User
12.4.5.2.1.
Pharmacies
12.4.5.2.2.
Healthcare
Payers
12.4.6. South Korea
12.4.6.1.
South
Korea Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By
Type
12.4.6.1.1.
Software
12.4.6.1.2.
Services
12.4.6.1.2.1. Medication Therapy Reviews
12.4.6.1.2.2. Pharmacotherapy Consults
12.4.6.1.2.3. Disease Management Support
12.4.6.1.2.4. Pharmacogenomics Applications
12.4.6.1.2.5. Anticoagulation Management
12.4.6.1.2.6. Medication Safety Surveillance
12.4.6.1.2.7. Other Clinical Services
12.4.6.2.
South
Korea Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By
End User
12.4.6.2.1.
Pharmacies
12.4.6.2.2.
Healthcare
Payers
12.4.7. Southeast Asia
12.4.7.1.
Southeast
Asia Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By
Type
12.4.7.1.1.
Software
12.4.7.1.2.
Services
12.4.7.1.2.1. Medication Therapy Reviews
12.4.7.1.2.2. Pharmacotherapy Consults
12.4.7.1.2.3. Disease Management Support
12.4.7.1.2.4. Pharmacogenomics Applications
12.4.7.1.2.5. Anticoagulation Management
12.4.7.1.2.6. Medication Safety Surveillance
12.4.7.1.2.7. Other Clinical Services
12.4.7.2.
Southeast
Asia Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By
End User
12.4.7.2.1.
Pharmacies
12.4.7.2.2.
Healthcare
Payers
12.4.7.3.
Southeast
Asia Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By
Country
12.4.7.3.1.
Indonesia
12.4.7.3.2.
Thailand
12.4.7.3.3.
Malaysia
12.4.7.3.4.
Singapore
12.4.7.3.5.
Rest of
Southeast Asia
12.4.8. Rest of Asia Pacific
12.4.8.1.
Rest of
Asia Pacific Medication Therapy Management Market Revenue (US$ Mn) and
Forecasts, By Type
12.4.8.1.1.
Software
12.4.8.1.2.
Services
12.4.8.1.2.1. Medication Therapy Reviews
12.4.8.1.2.2. Pharmacotherapy Consults
12.4.8.1.2.3. Disease Management Support
12.4.8.1.2.4. Pharmacogenomics Applications
12.4.8.1.2.5. Anticoagulation Management
12.4.8.1.2.6. Medication Safety Surveillance
12.4.8.1.2.7. Other Clinical Services
12.4.8.2.
Rest of
Asia Pacific Medication Therapy Management Market Revenue (US$ Mn) and
Forecasts, By End User
12.4.8.2.1.
Pharmacies
12.4.8.2.2.
Healthcare
Payers
12.5. Key Segment for Channeling Investments
12.5.1. By Country
12.5.2. By Type
12.5.3. By End User
13. Middle East and Africa Medication Therapy
Management Market Analysis and Forecasts, 2019 - 2027
13.1. Overview
13.1.1. Middle East and Africa Medication Therapy
Management Market Revenue (US$ Mn)
13.2. Middle East and Africa Medication Therapy
Management Market Revenue (US$ Mn) and Forecasts, By Type
13.2.1. Software
13.2.2. Services
13.2.2.1.
Medication
Therapy Reviews
13.2.2.2.
Pharmacotherapy
Consults
13.2.2.3.
Disease
Management Support
13.2.2.4.
Pharmacogenomics
Applications
13.2.2.5.
Anticoagulation
Management
13.2.2.6.
Medication
Safety Surveillance
13.2.2.7.
Other
Clinical Services
13.3. Middle East and Africa Medication Therapy
Management Market Revenue (US$ Mn) and Forecasts, By End User
13.3.1. Pharmacies
13.3.2. Healthcare Payers
13.4. Middle East and Africa Medication Therapy
Management Market Revenue (US$ Mn) and Forecasts, By Country
13.4.1. Saudi Arabia
13.4.1.1.
Saudi
Arabia Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By
Type
13.4.1.1.1.
Software
13.4.1.1.2.
Services
13.4.1.1.2.1. Medication Therapy Reviews
13.4.1.1.2.2. Pharmacotherapy Consults
13.4.1.1.2.3. Disease Management Support
13.4.1.1.2.4. Pharmacogenomics Applications
13.4.1.1.2.5. Anticoagulation Management
13.4.1.1.2.6. Medication Safety Surveillance
13.4.1.1.2.7. Other Clinical Services
13.4.1.2.
Saudi
Arabia Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By
End User
13.4.1.2.1.
Pharmacies
13.4.1.2.2.
Healthcare
Payers
13.4.2. UAE
13.4.2.1.
UAE
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By Type
13.4.2.1.1.
Software
13.4.2.1.2.
Services
13.4.2.1.2.1. Medication Therapy Reviews
13.4.2.1.2.2. Pharmacotherapy Consults
13.4.2.1.2.3. Disease Management Support
13.4.2.1.2.4. Pharmacogenomics Applications
13.4.2.1.2.5. Anticoagulation Management
13.4.2.1.2.6. Medication Safety Surveillance
13.4.2.1.2.7. Other Clinical Services
13.4.2.2.
UAE
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By End
User
13.4.2.2.1.
Pharmacies
13.4.2.2.2.
Healthcare
Payers
13.4.3. Egypt
13.4.3.1.
Egypt
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By Type
13.4.3.1.1.
Software
13.4.3.1.2.
Services
13.4.3.1.2.1. Medication Therapy Reviews
13.4.3.1.2.2. Pharmacotherapy Consults
13.4.3.1.2.3. Disease Management Support
13.4.3.1.2.4. Pharmacogenomics Applications
13.4.3.1.2.5. Anticoagulation Management
13.4.3.1.2.6. Medication Safety Surveillance
13.4.3.1.2.7. Other Clinical Services
13.4.3.2.
Egypt
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By End
User
13.4.3.2.1.
Pharmacies
13.4.3.2.2.
Healthcare
Payers
13.4.4. Kuwait
13.4.4.1.
Kuwait
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By Type
13.4.4.1.1.
Software
13.4.4.1.2.
Services
13.4.4.1.2.1. Medication Therapy Reviews
13.4.4.1.2.2. Pharmacotherapy Consults
13.4.4.1.2.3. Disease Management Support
13.4.4.1.2.4. Pharmacogenomics Applications
13.4.4.1.2.5. Anticoagulation Management
13.4.4.1.2.6. Medication Safety Surveillance
13.4.4.1.2.7. Other Clinical Services
13.4.4.2.
Kuwait
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By End
User
13.4.4.2.1.
Pharmacies
13.4.4.2.2.
Healthcare
Payers
13.4.5. South Africa
13.4.5.1.
South
Africa Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By
Type
13.4.5.1.1.
Software
13.4.5.1.2.
Services
13.4.5.1.2.1. Medication Therapy Reviews
13.4.5.1.2.2. Pharmacotherapy Consults
13.4.5.1.2.3. Disease Management Support
13.4.5.1.2.4. Pharmacogenomics Applications
13.4.5.1.2.5. Anticoagulation Management
13.4.5.1.2.6. Medication Safety Surveillance
13.4.5.1.2.7. Other Clinical Services
13.4.5.2.
South
Africa Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By
End User
13.4.5.2.1.
Pharmacies
13.4.5.2.2.
Healthcare
Payers
13.4.6. Rest of Middle East & Africa
13.4.6.1.
Rest of
Middle East & Africa Medication Therapy Management Market Revenue (US$ Mn)
and Forecasts, By Type
13.4.6.1.1.
Software
13.4.6.1.2.
Services
13.4.6.1.2.1. Medication Therapy Reviews
13.4.6.1.2.2. Pharmacotherapy Consults
13.4.6.1.2.3. Disease Management Support
13.4.6.1.2.4. Pharmacogenomics Applications
13.4.6.1.2.5. Anticoagulation Management
13.4.6.1.2.6. Medication Safety Surveillance
13.4.6.1.2.7. Other Clinical Services
13.4.6.2.
Rest of
Middle East & Africa Medication Therapy Management Market Revenue (US$ Mn)
and Forecasts, By End User
13.4.6.2.1.
Pharmacies
13.4.6.2.2.
Healthcare
Payers
13.5. Key Segment for Channeling Investments
13.5.1. By Country
13.5.2. By Type
13.5.3. By End User
14. Latin America Medication Therapy Management
Market Analysis and Forecasts, 2019 - 2027
14.1. Overview
14.1.1. Latin America Medication Therapy Management
Market Revenue (US$ Mn)
14.2. Latin America Medication Therapy Management
Market Revenue (US$ Mn) and Forecasts, By Type
14.2.1. Software
14.2.2. Services
14.2.2.1.
Medication
Therapy Reviews
14.2.2.2.
Pharmacotherapy
Consults
14.2.2.3.
Disease
Management Support
14.2.2.4.
Pharmacogenomics
Applications
14.2.2.5.
Anticoagulation
Management
14.2.2.6.
Medication
Safety Surveillance
14.2.2.7.
Other Clinical
Services
14.3. Latin America Medication Therapy Management
Market Revenue (US$ Mn) and Forecasts, By End User
14.3.1. Pharmacies
14.3.2. Healthcare Payers
14.4. Latin America Medication Therapy Management
Market Revenue (US$ Mn) and Forecasts, By Country
14.4.1. Brazil
14.4.1.1.
Brazil
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By Type
14.4.1.1.1.
Software
14.4.1.1.2.
Services
14.4.1.1.2.1. Medication Therapy Reviews
14.4.1.1.2.2. Pharmacotherapy Consults
14.4.1.1.2.3. Disease Management Support
14.4.1.1.2.4. Pharmacogenomics Applications
14.4.1.1.2.5. Anticoagulation Management
14.4.1.1.2.6. Medication Safety Surveillance
14.4.1.1.2.7. Other Clinical Services
14.4.1.2.
Brazil
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By End
User
14.4.1.2.1.
Pharmacies
14.4.1.2.2.
Healthcare
Payers
14.4.2. Argentina
14.4.2.1.
Argentina
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By Type
14.4.2.1.1.
Software
14.4.2.1.2.
Services
14.4.2.1.2.1. Medication Therapy Reviews
14.4.2.1.2.2. Pharmacotherapy Consults
14.4.2.1.2.3. Disease Management Support
14.4.2.1.2.4. Pharmacogenomics Applications
14.4.2.1.2.5. Anticoagulation Management
14.4.2.1.2.6. Medication Safety Surveillance
14.4.2.1.2.7. Other Clinical Services
14.4.2.2.
Argentina
Medication Therapy Management Market Revenue (US$ Mn) and Forecasts, By End
User
14.4.2.2.1.
Pharmacies
14.4.2.2.2.
Healthcare
Payers
14.4.3. Rest of Latin America
14.4.3.1.
Rest of
Latin America Medication Therapy Management Market Revenue (US$ Mn) and
Forecasts, By Type
14.4.3.1.1.
Software
14.4.3.1.2.
Services
14.4.3.1.2.1. Medication Therapy Reviews
14.4.3.1.2.2. Pharmacotherapy Consults
14.4.3.1.2.3. Disease Management Support
14.4.3.1.2.4. Pharmacogenomics Applications
14.4.3.1.2.5. Anticoagulation Management
14.4.3.1.2.6. Medication Safety Surveillance
14.4.3.1.2.7. Other Clinical Services
14.4.3.2.
Rest of
Latin America Medication Therapy Management Market Revenue (US$ Mn) and
Forecasts, By End User
14.4.3.2.1.
Pharmacies
14.4.3.2.2.
Healthcare
Payers
14.5. Key Segment for Channeling Investments
14.5.1. By Country
14.5.2. By Type
14.5.3. By End User
15. Competitive Benchmarking
15.1. Market Share Analysis, 2018
15.2. Global Presence and Growth Strategies
15.2.1. Mergers and Acquisitions
15.2.2. Product Launches
15.2.3. Investments Trends
15.2.4. R&D Initiatives
16. Player Profiles
16.1. AdhereHealth, LLC
16.1.1. Company Details
16.1.2. Company Overview
16.1.3. Product Offerings
16.1.4. Key Developments
16.1.5. Financial Analysis
16.1.6. SWOT Analysis
16.1.7. Business Strategies
16.2. Agadia Systems, Inc.
16.2.1. Company Details
16.2.2. Company Overview
16.2.3. Product Offerings
16.2.4. Key Developments
16.2.5. Financial Analysis
16.2.6. SWOT Analysis
16.2.7. Business Strategies
16.3. Aprexis HS LLC
16.3.1. Company Details
16.3.2. Company Overview
16.3.3. Product Offerings
16.3.4. Key Developments
16.3.5. Financial Analysis
16.3.6. SWOT Analysis
16.3.7. Business Strategies
16.4. AssureCare, LLC
16.4.1. Company Details
16.4.2. Company Overview
16.4.3. Product Offerings
16.4.4. Key Developments
16.4.5. Financial Analysis
16.4.6. SWOT Analysis
16.4.7. Business Strategies
16.5. Cardinal Health (Outcomes Inc.)
16.5.1. Company Details
16.5.2. Company Overview
16.5.3. Product Offerings
16.5.4. Key Developments
16.5.5. Financial Analysis
16.5.6. SWOT Analysis
16.5.7. Business Strategies
16.6. Centene Corporation (WellCare)
16.6.1. Company Details
16.6.2. Company Overview
16.6.3. Product Offerings
16.6.4. Key Developments
16.6.5. Financial Analysis
16.6.6. SWOT Analysis
16.6.7. Business Strategies
16.7. Cerner Corporation
16.7.1. Company Details
16.7.2. Company Overview
16.7.3. Product Offerings
16.7.4. Key Developments
16.7.5. Financial Analysis
16.7.6. SWOT Analysis
16.7.7. Business Strategies
16.8. CSS Health
16.8.1. Company Details
16.8.2. Company Overview
16.8.3. Product Offerings
16.8.4. Key Developments
16.8.5. Financial Analysis
16.8.6. SWOT Analysis
16.8.7. Business Strategies
16.9. First Databank, Inc.
16.9.1. Company Details
16.9.2. Company Overview
16.9.3. Product Offerings
16.9.4. Key Developments
16.9.5. Financial Analysis
16.9.6. SWOT Analysis
16.9.7. Business Strategies
16.10. GemCare Wellness
16.10.1. Company Details
16.10.2. Company Overview
16.10.3. Product Offerings
16.10.4. Key Developments
16.10.5. Financial Analysis
16.10.6. SWOT Analysis
16.10.7. Business Strategies
16.11. General Electric Company
16.11.1. Company Details
16.11.2. Company Overview
16.11.3. Product Offerings
16.11.4. Key Developments
16.11.5. Financial Analysis
16.11.6. SWOT Analysis
16.11.7. Business Strategies
16.12. Healthcare Fiscal Management, Inc.
16.12.1. Company Details
16.12.2. Company Overview
16.12.3. Product Offerings
16.12.4. Key Developments
16.12.5. Financial Analysis
16.12.6. SWOT Analysis
16.12.7. Business Strategies
16.13. IQware Solutions
16.13.1. Company Details
16.13.2. Company Overview
16.13.3. Product Offerings
16.13.4. Key Developments
16.13.5. Financial Analysis
16.13.6. SWOT Analysis
16.13.7. Business Strategies
16.14. Magellan Health, Inc.
16.14.1. Company Details
16.14.2. Company Overview
16.14.3. Product Offerings
16.14.4. Key Developments
16.14.5. Financial Analysis
16.14.6. SWOT Analysis
16.14.7. Business Strategies
16.15. McKesson Corporation
16.15.1. Company Details
16.15.2. Company Overview
16.15.3. Product Offerings
16.15.4. Key Developments
16.15.5. Financial Analysis
16.15.6. SWOT Analysis
16.15.7. Business Strategies
16.16. Omnicell, Inc.
16.16.1. Company Details
16.16.2. Company Overview
16.16.3. Product Offerings
16.16.4. Key Developments
16.16.5. Financial Analysis
16.16.6. SWOT Analysis
16.16.7. Business Strategies
16.17. Tabula Rasa HealthCare (Sinfonia Rx)
16.17.1. Company Details
16.17.2. Company Overview
16.17.3. Product Offerings
16.17.4. Key Developments
16.17.5. Financial Analysis
16.17.6. SWOT Analysis
16.17.7. Business Strategies
16.18. Other Market Participants
17. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and
Enterprise User
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
